Transgene SA
TRGNF
$0.70
-$0.89-55.98%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -40.03M | -37.96M | -36.75M | -30.89M | -24.78M |
| Total Depreciation and Amortization | 1.46M | 1.41M | 1.39M | 1.44M | 1.49M |
| Total Amortization of Deferred Charges | 1.50M | 1.50M | 1.50M | 5.12M | 8.77M |
| Total Other Non-Cash Items | -1.15M | -2.24M | -3.24M | -10.38M | -17.57M |
| Change in Net Operating Assets | 13.18M | 12.45M | 11.65M | 2.77M | -6.36M |
| Cash from Operations | -25.05M | -24.85M | -25.46M | -31.95M | -38.45M |
| Capital Expenditure | -1.45M | -2.38M | -3.32M | -3.43M | -3.54M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.10M | -620.60K | -152.50K | 9.88M | 20.02M |
| Cash from Investing | -2.55M | -3.00M | -3.47M | 6.44M | 16.49M |
| Total Debt Issued | 300.00K | 150.00K | 0.00 | 10.00M | 20.00M |
| Total Debt Repaid | -90.00K | -665.00K | -1.24M | -1.49M | -1.75M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 27.56M | 27.88M | 28.20M | 20.73M | 13.27M |
| Cash from Financing | 30.28M | 29.26M | 29.15M | 31.65M | 34.09M |
| Foreign Exchange rate Adjustments | -1.10M | -90.40K | 864.40K | 651.70K | 432.40K |
| Miscellaneous Cash Flow Adjustments | -1.10K | -500.00 | -- | -- | -- |
| Net Change in Cash | 1.57M | 1.33M | 1.09M | 6.80M | 12.56M |